Issued Patents 2018
Showing 1–6 of 6 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10138248 | Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors | Andrew W. Buesking, Richard B. Sparks, Andrew P. Combs, Brent Douty, Nikoo Falahatpisheh +2 more | 2018-11-27 |
| 10092570 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Wenqing Yao, Andrew P. Combs, Song Mei, Wenyu Zhu +5 more | 2018-10-09 |
| 10065963 | Heterocyclic compounds as PI3K-γ inhibitors | Artem Shvartsbart, Stacey Shepard, Andrew P. Combs, Lixin Shao, Nikoo Falahatpisheh +2 more | 2018-09-04 |
| 10034864 | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | Andrew P. Combs, Richard B. Sparks, Wenyu Zhu | 2018-07-31 |
| 9932341 | Use of pyrazolopyrimidine derivatives for the treatment of PI3K-delta related disorders | Yun-Long Li, Andrew P. Combs, Song Mei, Brent Douty | 2018-04-03 |
| 9918990 | Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors | Andrew P. Combs, Brent Douty | 2018-03-20 |